What Happens in the Brain? S2Treating Alcohol Abuse and Dependence S5CME Post-Test S10CME Registration/Evaluation Form S11
Vice Chair, Department of Psychiatry Director of Addiction Medicine Cedars-Sinai Medical Center Adjunct Professor of Psychiatry University of California, Los Angeles
Contents
Faculty
Vice Chair, Department of Psychiatry Director of Addiction Medicine Cedars-Sinai Medical Center Adjunct Professor of Psychiatry University of California, Los Angeles
Professor of Psychiatry University of California, San Diego Director, Alcohol Research Center San Diego Veterans Affairs Medical Center San Diego
Professor of Neuropharmacology Director, Division of Clinical Psychopharmacology Codirector, Pearson Center for Alcoholism and Addiction Research Scripps Research Institute La Jolla, Calif
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.
